Truist Securities Maintains Hold on OrthoPediatrics, Raises Price Target to $32
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Samuel Brodovsky has maintained a Hold rating on OrthoPediatrics (NASDAQ:KIDS) and increased the price target from $31 to $32.

March 08, 2024 | 2:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities has maintained a Hold rating on OrthoPediatrics and raised the price target from $31 to $32.
The increase in price target by Truist Securities suggests a positive outlook on OrthoPediatrics' stock value in the short term, potentially leading to an upward movement in its stock price. However, the Hold rating indicates that the analyst sees the stock as fairly valued at its current price, suggesting limited upside potential.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100